New Delhi: Serum Institute of India CEO Adar Poonawalla urged countries that are waiting for the corona virus vaccine Covishield to be patient. SII is producing the ‘Covishield’ vaccine developed by Oxford University and the British-Swedish company AstraZeneca. Adar Poona Wala wrote this morning via his Twitter account that dear countries and governments, as you all are waiting for the supply of Covishield, I request you all to be patient.
Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he added.
“Dear countries and governments, as you await #COVISHIELD supplies, I humbly request you to please be patient, @SerumInstIndia has been directed to prioritise the huge needs of India and along with that balance the needs of the rest of the world. We are trying our best”, Poonawalla said in a tweet.
On February 15, the World Health Organisation (WHO) listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX.
The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.